• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CU6

CLARITY PHARMACEUTICALS LTD - Charts / Financials

5.34% ! $2.17
Market Cap $766.8M  !
Healthcare Biotechnology
Add to My Watchlist

Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical... Clarity Pharmaceuticals Ltd is an Australia-based clinical-stage radiopharmaceutical company. The Company is focused on developing theranostic (therapy and imaging) products, based on its platform SAR Technology. It is progressing seven clinical trials with its three key products, SARTATE, SAR-bisPSMA, and SAR-Bombesin. SARTATE is developed for diagnosing, staging, and treating cancers that express somatostatin receptor 2 (SSTR2), including neuroblastoma and neuroendocrine tumors (NETs). SAR-bisPSMA is developed for diagnosing, staging, and treating cancers that express Prostate Specific Membrane Antigen (PSMA). SAR-Bombesin is developed for identifying and selecting patients for subsequent treatment of cancers that express a specific receptor called the gastrin releasing peptide receptor (GRPr), including breast cancer and prostate cancer. It has a diverse range of products in clinical trials, which address both large indications as well as rare and orphan indications of cancer.More

refresh Created with Sketch. REFRESH
Last update - 16.26pm 12/06/2026 (20 minute delay) ?
Day
Open $2.11   Day High $2.20   Day Low $2.09
Daily Volume 2081315
Bids   Sellers
Number Price Volume   Number Price Volume
0 $2.14 30037   0 $2.18 23566

Directors & Senior Management

Dr. Alan John Taylor Executive Chairman
Dr. Andrei Iagaru Member of Scientific Advisory Board
Mr. Chris Horvath Chief Commercial Officer
Dr. Christopher Graham Roberts Non-Executive Director
Dr. Colin David Biggin Chief Operating Officer
Mr. David K. Green Chief Financial Officer
Dr. Ellen van Dam Chief Scientific Officer
Ms. Eva Lengyelova Executive Vice President of Clinical Development
Prof. Jason S. Lewis Member of Scientific Advisory Board
Mr. Jon Stoner Member of Scientific Advisory Board
Ms. Lisa Sadetskaya Director of Corporate Communications.
Prof. Louise Emmett Member of Scientific Advisory Board
Ms. Mary Bennett Head of People & Culture
Ms. Michelle Parker CEO, MD & Executive Director
Dr. Neal D. Shore Member of Scientific Advisory Board
Dr. Oliver Sartor Member of Scientific Advisory Board
Dr. Othon Gervasio Chief Medical Officer
Prof. Paul Donnelly Member of Scientific Advisory Board
Mr. Robert Vickery Company Secretary
Ms. Rosanne Elizabeth Robinson Lead Independent Non-Executive Director
Mr. Shaemus Gleason Executive Vice President of Operations
Dr. Thomas Ramdahl Non-Executive Director

Data source: ADVFN

Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
$2.17 		Change
0.110(5.34%) 		Mkt cap ! $766.8M
Open High Low Volume
$2.11 $2.20 $2.09 2.081M

Buyers (Bids)

Vol. Price($)
30037 $2.14
 

Sellers (Offers)

Price($) Vol.
$2.18 23566
Last trade - 16.26pm 12/06/2026 (20 minute delay) ?

Top Stories

From the Wire: Boresight's debut, 1414's Ukraine pivot prove drones are the ASX's favourite trade

The ASX has a new drone darling @ and a drone double feature, if you can believe it. Boresight (ASX:BST), the Canberra-based maker of target drones built to be shot down, popped on its Wednesday debut, while 1414 Degrees (ASX:14D) halted to announce a Ukrainian drone-battery deal.Listen to the Ho...
HotCopper Highlights, Week 24: Defence stocks soar on drone pivot, lithium debate rages on Boresight's explosive ASX debut, ongoing lithium debate, rising interest in defence tech: all the themes dominating HotCopper discussion this week.
From the Wire: Why Oz traders are retreating to supermarkets & other staple stocks Australian traders are reaching for the pantry staples. With gold sliding towards US$4,000, iron ore largely stuck, and an RBA meeting looming, Week 24 has delivered a @textbook defensive rotation” @ and HotCopper Wire hosts Isaac McIntyre and Jonathon Davidson reckon superm...
Lithium will surge again. This explorer has a secret weapon for when it does Prairie Lithium is a company actively differentiating by building through the lithium downturn, rather than waiting for sentiment to return.
Dale Gillham: Has crypto lost its magic? Investors rethink 'digital gold' narrative Bitcoin and the crypto market built its reputation on a simple promise: buy and hold it, and eventually you’ll be rewarded, but right now, that belief is being tested. Following one of its biggest declines in recent years, roughly half of all Bitcoin holders are now sitting on a l...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.